Earnings Feed
Start Free
Home/Filings/4/0001140361-12-038935
4//SEC Filing

BODY CENTRAL CORP 4

Accession 0001140361-12-038935

CIK 0001379246operating
View on SEC.govCompany Profile

Filed

Aug 29, 8:00 PM ET

Accepted

Aug 30, 5:00 PM ET

Size

14.7 KB

Accession

0001140361-12-038935

Insider Transaction Report

Form 4
Period: 2012-08-28
BODY CENTRAL CORPBODY
WEINSTEIN ALLEN
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2012-08-29$3.94/sh+2,100$8,274→ 23,072 total
  • Exercise/Conversion

    Common Stock

    2012-08-28$3.94/sh+4,000$15,760→ 24,972 total
  • Sale

    Common Stock

    2012-08-28$8.82/sh−4,000$35,265→ 20,972 total
  • Sale

    Common Stock

    2012-08-29$8.91/sh−2,100$18,713→ 20,972 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2012-08-28−4,000→ 120,882 total
    Exercise: $3.94Exp: 2019-10-12→ Common Stock (4,000 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2012-08-29−2,100→ 118,782 total
    Exercise: $3.94Exp: 2019-10-12→ Common Stock (2,100 underlying)
Footnotes (4)
  • [F1]Includes 20,972 restricted shares granted pursuant to the Company's Equity Incentive Plan, 10,122 of which 25% vest on September 16, 2012, with the balance vesting in 12 equal quarterly installments and 10,850 of which 25% vest on April 16, 2013, with the balance vesting in 12 equal quarterly installments.
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.80 to $8.85, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.90 to $9.00, inclusive. The reporting person undertakes to provide to Body Central Corp., any security holder of Body Central Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  • [F4]Shares subject to vesting ending August 3, 2013.

Documents

1 file

Issuer

BODY CENTRAL CORP

CIK 0001379246

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001379246

Filing Metadata

Form type
4
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 5:00 PM ET
Size
14.7 KB
View on SEC.gov